Journal article
Do BRCA1 and BRCA2 gene mutation carriers have a reduced ovarian reserve? Protocol for a prospective observational study
AL Winship, C Willson, KR Hansen, KJ Hutt, M Hickey
BMJ Open | BMJ PUBLISHING GROUP | Published : 2019
Abstract
Introduction BRCA1/2 gene mutations increase risk of breast and/or ovarian cancer and may have implications for reproductive health. Indirect biomarkers of the ovarian primordial follicle pool (anti-Müllerian hormone (AMH)) and one small study in female cadavers suggest that ovarian reserve may be reduced in BRCA mutation carriers, but findings are conflicting and association between circulating AMH and primordial follicle number is not established. The aim of this study is to measure primordial follicle density in premenopausal ovarian tissue samples from women with BRCA1/2 gene mutations versus age-matched comparison group. Methods and analysis Prospective observational study measuring ass..
View full abstractRelated Projects (1)
Grants
Awarded by National Health and Medical Research Council
Funding Acknowledgements
This work was made possible through Victorian State Government Operational Infrastructure Support and Australian Government NHMRC IRIISS. This work was supported by funding from the National Health and Medical Research Council (NHMRC); AW was supported by an NHMRC Early Career Fellowship (1120300). The manufacturer of the anti-Mullerian hormone assay provided the consumables to perform the analysis but has no input in regards to any data or content reported.